Ladenburg Thalmann Financial Services’s Intellia Therapeutics NTLA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$80K	Buy	5,418 +300	+6%	+$4.17K	﹤0.01%	3182
2019 Q3	$68K	Buy	5,118 +905	+21%	+$14.4K	﹤0.01%	3219
2019 Q2	$69K	Sell	4,213 -2,743	-39%	-$43.1K	﹤0.01%	3237
2019 Q1	$119K	Buy	6,956 +1,885	+37%	+$28.1K	﹤0.01%	2776
2018 Q4	$70K	Buy	5,071 +208	+4%	+$3.87K	﹤0.01%	3017
2018 Q3	$140K	Buy	4,863 +928	+24%	+$27K	﹤0.01%	2584
2018 Q2	$83K	Hold	3,935	–	–	﹤0.01%	2870
2018 Q1	$83K	Buy	3,935 +1,035	+36%	+$25.5K	﹤0.01%	2870
2017 Q4	$56K	Buy	2,900 +1,800	+164%	+$41.6K	﹤0.01%	3139
2017 Q3	$27K	Buy	1,100 +1,000	+1,000%	+$18.8K	﹤0.01%	3506
2017 Q2	$2K	Hold	100	–	–	﹤0.01%	4610
2017 Q1	$1K	Buy	+100	New	+$1.34K	﹤0.01%	4727

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NTLA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Intellia Therapeutics (NTLA) stake by 5.9% in Q4 2019, buying an estimated $4.17K and bringing the position to 5,418 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #3182.

Ladenburg Thalmann Financial Services first reported a position in NTLA in Q1 2017 and has held it in 12 quarters since. The position peaked at $140K in Q3 2018. 143 funds tracked by Wall St. Rank hold NTLA as of Q4 2019.

Ladenburg Thalmann Financial Services held 5,418 shares of Intellia Therapeutics worth $80K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 300 Intellia Therapeutics shares in Q4 2019, an estimated $4.17K.
Intellia Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3182 holding.
Ladenburg Thalmann Financial Services first reported a position in Intellia Therapeutics in Q1 2017 and has held it in 12 quarters since.
Ladenburg Thalmann Financial Services's Intellia Therapeutics position peaked at $140K in Q3 2018.
143 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.